Nuvelo Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Nuvelo General Information

Description

Developer of drugs focused on the discovery, development and commercialization of therapeutics that improve life. The company produces novel drugs for acute cardiovascular and cancer therapy, thereby providing medical solutions to clients.

Contact Information

Website
www.nuvelo.com
Formerly Known As
Hyseq, ARCA biopharma
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 201 Industrial Road
  • Suite 310
  • San Carlos, CA 94070-6211
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 201 Industrial Road
  • Suite 310
  • San Carlos, CA 94070-6211
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuvelo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nuvelo‘s full profile, request access.

Request a free trial

Nuvelo Patents

Nuvelo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2220247-A2 Antibodies to lrp6 Inactive 16-Nov-2007
EP-2220247-A4 Antibodies to lrp6 Inactive 16-Nov-2007
EP-3211011-A1 Antibodies to lrp6 Inactive 16-Nov-2007
WO-2009064944-A2 Antibodies to lrp6 Inactive 16-Nov-2007
WO-2009064944-A3 Antibodies to lrp6 Inactive 16-Nov-2007 C07K16/28
To view Nuvelo’s complete patent history, request access »

Nuvelo Acquisitions (1)

Nuvelo’s most recent deal was a Reverse Merger with Arca Biopharma. The deal was made on 28-Jan-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Arca Biopharma 28-Jan-2009 Reverse Merger Drug Discovery
To view Nuvelo’s complete acquisitions history, request access »

Nuvelo Exits (1)

Nuvelo’s most recent exit was on 28-Jan-2009 from Arca Biopharma. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Arca Biopharma 28-Jan-2009 Completed
To view Nuvelo’s complete exits history, request access »

Nuvelo FAQs

  • When was Nuvelo founded?

    Nuvelo was founded in 1992.

  • Where is Nuvelo headquartered?

    Nuvelo is headquartered in San Carlos, CA.

  • What industry is Nuvelo in?

    Nuvelo’s primary industry is Drug Discovery.

  • Is Nuvelo a private or public company?

    Nuvelo is a Private company.

  • What is the current valuation of Nuvelo?

    The current valuation of Nuvelo is .

  • What is Nuvelo’s current revenue?

    The current revenue for Nuvelo is .

  • When was Nuvelo acquired?

    Nuvelo was acquired on 27-Jan-2009.

  • Who acquired Nuvelo?

    Nuvelo was acquired by Arca Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process